Crinetics Pharmaceuticals Inc

Financials

Fluxo de caixa operacional -62.65 M-88.45 M-85.85 M-110.72 M-92.9 M -377.92 M Fluxo de caixa de investimento -542.09 M-85.96 M37.95 M164.81 M57.11 M 173.91 M Fluxo de caixa de financiamento 552.01 M4.44 M7.05 M3.08 M26.04 M 40.61 M Fluxo de caixa livre -63.68 M-89.69 M-89.05 M-111.58 M-93.36 M -383.68 M

Crinetics Pharmaceuticals is a global pharmaceutical company known for developing drugs for the treatment of endocrine-related diseases. It was founded by Scott Struthers, Frank Zhu, Ana Kusnetzow, and Stephen F. Betz in 2008 and is headquartered in San Diego, California. It went public on NASDAQ in 2018.

CRNX

Financials

Crinetics Pharmaceuticals Inc

Notícias

Crinetics submete pedido de aprovação de medicamento para acromegalia no Brasil

Diretor de desenvolvimento e operações da Crinetics Pharmaceuticals vai renunciar

Neurocrine Biosciences: The Song Remains The Same (NASDAQ:NBIX)

Diretor da Crinetics Pharma vende US$ 180 mil em ações

Crinetics Pharma director Vivaldi Coelho sells $180k in stock

CFO da Crinetics Pharma vende US$ 266 mil em ações

Crinetics Pharma CFO Schilke sells $266k in stock

Citizens reduz preço-alvo da Crinetics após revisão de avaliação

Citizens lowers Crinetics stock price target on valuation review

Crinetics Pharmaceuticals, Inc. (CRNX) Q4 2025 Earnings Call Transcript

Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q4 Loss, Beats Revenue Estimates

Lucro da Crinetics Pharma superou projeções por $0,05; receita supera estimativas